Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Northeast Regional Epilepsy Group (NREG) is a leading specialized medical practice dedicated to the diagnosis and treatment of epilepsy and seizure disorders in the New York and New Jersey metropolitan areas. The group provides comprehensive care through a multidisciplinary team of epileptologists, neurosurgeons, and neuropsychologists, offering advanced diagnostic testing such as video-EEG monitoring and neuroimaging. NREG is heavily involved in clinical research, serving as a major site for numerous Phase 1-3 clinical trials for novel antiepileptic drugs and medical devices. Their services include medical management, surgical evaluations, vagus nerve stimulation (VNS), and specialized dietary therapies like the ketogenic diet. The organization operates multiple clinical centers and is affiliated with several major regional hospital systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Northeast Regional Epilepsy Group.